- Home
- WINT vs OCTO Comparison
WINT vs OCTO Comparison
Compare WINT & OCTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- OCTO
- Stock Information
- Founded
- WINT 1992
- OCTO 1966
- Country
- WINT United States
- OCTO United States
- Employees
- WINT N/A
- OCTO N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- OCTO
- Sector
- WINT Health Care
- OCTO
- Exchange
- WINT Nasdaq
- OCTO Nasdaq
- Market Cap
- WINT 2.2M
- OCTO 4.2M
- IPO Year
- WINT 1995
- OCTO N/A
- Fundamental
- Price
- WINT $0.14
- OCTO $1.51
- Analyst Decision
- WINT Hold
- OCTO
- Analyst Count
- WINT 1
- OCTO 0
- Target Price
- WINT $350.00
- OCTO N/A
- AVG Volume (30 Days)
- WINT 5.2M
- OCTO 3.0M
- Earning Date
- WINT 08-26-2025
- OCTO 08-19-2025
- Dividend Yield
- WINT N/A
- OCTO N/A
- EPS Growth
- WINT N/A
- OCTO N/A
- EPS
- WINT N/A
- OCTO N/A
- Revenue
- WINT N/A
- OCTO $43,871,615.00
- Revenue This Year
- WINT N/A
- OCTO N/A
- Revenue Next Year
- WINT N/A
- OCTO N/A
- P/E Ratio
- WINT N/A
- OCTO N/A
- Revenue Growth
- WINT N/A
- OCTO N/A
- 52 Week Low
- WINT $0.10
- OCTO $0.98
- 52 Week High
- WINT $662.00
- OCTO $4.86
- Technical
- Relative Strength Index (RSI)
- WINT 24.01
- OCTO 51.06
- Support Level
- WINT $0.45
- OCTO $1.33
- Resistance Level
- WINT $0.51
- OCTO $1.63
- Average True Range (ATR)
- WINT 0.08
- OCTO 0.10
- MACD
- WINT -0.05
- OCTO -0.02
- Stochastic Oscillator
- WINT 8.93
- OCTO 58.14
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About OCTO Eightco Holdings Inc.
Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business.